Burden of Glomerular Diseases in Australia: A Data Linkage Study.

Neeru Agarwal, Kristy P Robledo, Angus Ritchie, Amali Mallawaarachchi, Carol A Pollock, Meg J Jardine

Abstract read

In one paragraph

Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Neeru AgarwalNHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Kristy P RobledoNHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Angus RitchieConcord Repatriation General Hospital, Concord, NSW, Australia.

Amali MallawaarachchiClinical Genetics Service, Institute of Precision Medicine and Bioinformatics, Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Carol A PollockDepartment of Renal Medicine, Royal North Shore Hospital, Sydney, NSW, Australia.

Meg J JardineNHMRC Clinical Trials Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Glomerular diseases are rare but associated with substantial morbidity. Existing studies focus mainly on kidney failure and mortality, often overlooking multisystem complications. This first Australian population-based study uses linked routinely collected health data to estimate incidence, prevalence, and long-term outcomes, capturing cardiovascular, thrombotic, infectious, and healthcare burdens. Methods: We conducted a population-based cohort study of adults ≥45 years in New South Wales, Australia (2005-2009, Results: We identified 365 participants with glomerular disease ( Conclusions: Using linked data, this study reveals the substantial multisystem burden of glomerular diseases, including kidney failure, death, cardiovascular events, infections, and hospitalisations in adults aged 45 and over.

Indexed as

Cardiovascular outcomesData linkageGlomerular diseaseHospitalisationKidney replacement therapy

Identifiers

PMID41970646

DOI10.1159/000550827

PMCPMC13065309

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.